The Ensign Group, Inc. $ENSG Shares Sold by Copeland Capital Management LLC

Copeland Capital Management LLC lessened its stake in The Ensign Group, Inc. (NASDAQ:ENSG) by 5.3% in the fourth quarter, Holdings Channel reports. The firm owned 641,400 shares of the company’s stock after selling 35,799 shares during the quarter. The Ensign Group accounts for about 2.5% of Copeland Capital Management LLC’s investment portfolio, making the stock its largest position. Copeland Capital Management LLC’s holdings in The Ensign Group were worth $111,732,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also bought and sold shares of ENSG. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its stake in The Ensign Group by 9.9% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 161,946 shares of the company’s stock valued at $20,956,000 after purchasing an additional 14,590 shares in the last quarter. Geneos Wealth Management Inc. raised its stake in The Ensign Group by 150.3% in the first quarter. Geneos Wealth Management Inc. now owns 383 shares of the company’s stock valued at $50,000 after purchasing an additional 230 shares in the last quarter. EverSource Wealth Advisors LLC raised its stake in The Ensign Group by 65.9% in the second quarter. EverSource Wealth Advisors LLC now owns 536 shares of the company’s stock valued at $83,000 after purchasing an additional 213 shares in the last quarter. Amundi raised its stake in The Ensign Group by 480,216.7% in the second quarter. Amundi now owns 57,638 shares of the company’s stock valued at $8,583,000 after purchasing an additional 57,626 shares in the last quarter. Finally, Brown Advisory Inc. raised its stake in The Ensign Group by 26.1% in the second quarter. Brown Advisory Inc. now owns 2,037 shares of the company’s stock valued at $314,000 after purchasing an additional 421 shares in the last quarter. Institutional investors and hedge funds own 96.12% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts recently commented on ENSG shares. Truist Financial set a $215.00 price target on The Ensign Group and gave the company a “hold” rating in a research note on Friday, February 6th. UBS Group set a $230.00 target price on The Ensign Group and gave the company a “buy” rating in a research report on Friday, February 6th. Wall Street Zen upgraded The Ensign Group from a “hold” rating to a “buy” rating in a research report on Saturday, February 7th. Royal Bank Of Canada reiterated an “outperform” rating and issued a $222.00 target price (up from $206.00) on shares of The Ensign Group in a research report on Monday, February 9th. Finally, Weiss Ratings reiterated a “buy (b)” rating on shares of The Ensign Group in a research report on Tuesday. Five analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $204.60.

The Ensign Group Stock Performance

The Ensign Group stock opened at $189.34 on Friday. The Ensign Group, Inc. has a 12-month low of $123.56 and a 12-month high of $218.00. The company has a quick ratio of 1.42, a current ratio of 1.42 and a debt-to-equity ratio of 0.06. The business’s 50-day moving average price is $204.66 and its two-hundred day moving average price is $188.85. The stock has a market cap of $10.97 billion, a PE ratio of 32.42, a P/E/G ratio of 1.83 and a beta of 0.81.

The Ensign Group (NASDAQ:ENSG) last released its earnings results on Wednesday, February 4th. The company reported $1.82 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.75 by $0.07. The Ensign Group had a return on equity of 16.76% and a net margin of 6.80%.The firm had revenue of $1.36 billion for the quarter, compared to analysts’ expectations of $1.37 billion. During the same quarter in the previous year, the business posted $1.49 earnings per share. The business’s revenue for the quarter was up 20.2% on a year-over-year basis. The Ensign Group has set its FY 2026 guidance at 7.410-7.610 EPS. As a group, analysts expect that The Ensign Group, Inc. will post 6.79 earnings per share for the current fiscal year.

The Ensign Group Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Thursday, April 30th. Shareholders of record on Tuesday, March 31st will be given a $0.065 dividend. This represents a $0.26 dividend on an annualized basis and a yield of 0.1%. The ex-dividend date is Tuesday, March 31st. The Ensign Group’s payout ratio is currently 4.45%.

Insider Transactions at The Ensign Group

In other news, Director John O. Agwunobi sold 392 shares of the business’s stock in a transaction dated Monday, April 20th. The stock was sold at an average price of $199.97, for a total transaction of $78,388.24. Following the sale, the director directly owned 9,295 shares in the company, valued at approximately $1,858,721.15. The trade was a 4.05% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO Suzanne D. Snapper sold 8,258 shares of the business’s stock in a transaction dated Thursday, February 5th. The stock was sold at an average price of $194.48, for a total value of $1,606,015.84. Following the sale, the chief financial officer owned 277,462 shares in the company, valued at approximately $53,960,809.76. This trade represents a 2.89% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last 90 days, insiders have sold 17,173 shares of company stock valued at $3,377,311. Company insiders own 4.00% of the company’s stock.

About The Ensign Group

The Ensign Group, Inc is a diversified provider of post-acute healthcare services in the United States, operating a network of skilled nursing, assisted living, independent living, home health and hospice care centers. The company’s model emphasizes integrated care by employing multidisciplinary teams—including nursing staff, therapists and physicians—to deliver personalized rehabilitation and long-term care services for seniors and other patients recovering from injury, illness or surgery.

Through its owned and managed centers, The Ensign Group offers a broad spectrum of rehabilitation services such as physical, occupational and speech therapy.